Status:
COMPLETED
Whipple Protein Study
Lead Sponsor:
Thomas Jefferson University
Conditions:
Pancreatic Cancer
Malnutrition
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Study investigators aim to assess the effect of providing high-protein nutritional supplementation before and after surgery
Detailed Description
Pancreaticoduodenectomy (PD) is a complex and morbid operation that is associated with many potential complications. Many people undergoing PD are malnourished due to their underlying medical conditio...
Eligibility Criteria
Inclusion
- Patients undergoing pancreaticoduodenectomy
- Patients aged 18 years and older
- Patients able to provide written informed consent
- Patients able to understand and comply with study guidelines
- Patients able to tolerate oral intake
- Patients who are malnourished or at risk of malnutrition as defined by a score less than 12 on the Mini-Nutritional Assessment
Exclusion
- Patients with a milk protein allergy
- Patients with a vegan diet
- Patients dependent on artificial enteral feeding
- Patients with end-stage renal disease undergoing dialysis
- Patients who are pregnant
- Patients with ongoing eating disorder or condition precluding oral intake
- Patients who are scheduled for pancreaticoduodenectomy but are unable to receive this surgery
Key Trial Info
Start Date :
August 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04306874
Start Date
August 20 2019
End Date
November 15 2022
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107